Scarica l'app Stockscreener
17.17
1.27%
-0.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$17.39
Aprire:
$17.3
Volume 24 ore:
19.92M
Relative Volume:
1.75
Capitalizzazione di mercato:
$20.00B
Reddito:
$14.29B
Utile/perdita netta:
$-3.51B
Rapporto P/E:
-5.8001
EPS:
-2.9603
Flusso di cassa netto:
$1.85B
1 W Prestazione:
+14.16%
1M Prestazione:
+26.53%
6M Prestazione:
+69.66%
1 anno Prestazione:
+88.89%
Intervallo 1D:
$16.65
$17.53
Intervallo di 1 settimana:
$14.82
$17.53
Portata 52W:
$8.19
$17.53
Viatris Inc Stock (VTRS) Company Profile
Nome
Viatris Inc
Settore
Telefono
(724) 514-1465
Indirizzo
1000 MYLAN BOULEVARD, CANONSBURG
Compare VTRS vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
VTRS
Viatris Inc
|
17.17 | 20.00B | 14.29B | -3.51B | 1.85B | -2.9603 |
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 52.00B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.73 | 41.60B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 40.43B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
82.83 | 34.72B | 9.47B | 2.67B | 2.28B | 6.0218 |
UTHR
United Therapeutics Corp
|
564.94 | 23.98B | 3.18B | 1.33B | 1.04B | 27.90 |
Viatris Inc Stock (VTRS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | UBS | Neutral → Buy |
| 2026-01-16 | Aggiornamento | Argus | Hold → Buy |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-15 | Iniziato | Truist | Buy |
| 2025-06-06 | Iniziato | Goldman | Neutral |
| 2024-07-19 | Ripresa | Jefferies | Buy |
| 2023-10-23 | Downgrade | BofA Securities | Neutral → Underperform |
| 2023-06-23 | Downgrade | Barclays | Equal Weight → Underweight |
| 2023-04-24 | Downgrade | Barclays | Overweight → Equal Weight |
| 2023-02-17 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2023-01-27 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-11-10 | Aggiornamento | UBS | Sell → Neutral |
| 2022-11-08 | Aggiornamento | Piper Sandler | Underweight → Neutral |
| 2022-10-21 | Ripresa | Jefferies | Hold |
| 2022-06-14 | Iniziato | UBS | Sell |
| 2022-05-10 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2022-03-01 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-01 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2021-06-15 | Iniziato | Citigroup | Neutral |
| 2021-04-07 | Ripresa | RBC Capital Mkts | Outperform |
| 2021-03-08 | Downgrade | Goldman | Buy → Neutral |
| 2021-03-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2021-01-05 | Iniziato | Argus | Hold |
| 2020-12-14 | Iniziato | Bernstein | Mkt Perform |
Mostra tutto
Viatris Inc Borsa (VTRS) Ultime notizie
Viatris Earnings Call Highlights Profits, Pipeline Momentum - The Globe and Mail
HHS officials considered banning SSRI antidepressantsreport - Seeking Alpha
Viatris Inc. stock falls Friday, underperforms market - MarketWatch
Research Alert: CFRA Keeps Hold Opinion On Shares Of Viatris Inc. - Moomoo
Viatris gears up to report Q1 earnings: What's in the cards? - MSN
symbol__ Stock Quote Price and Forecast - CNN
Viatris CFO leaving Canonsburg pharma giant - MSN
Hypercholesterolemia Treatment Market is expected to Hit US$ - openPR.com
Viatris: Q1 Earnings Snapshot - theheraldreview.com
Viatris Inc. Stock 12‑Month Price Target Raised to $17.25, Implies 1% Downside - TradingView
Viatris to Present at the Bank of America Securities 2026 Healthcare Conference - BioSpace
VTRS Q1 Deep Dive: China Strength, R&D Pipeline, and Execution Drive Outperformance - TradingView
5-Day Rally Sends Viatris Stock Up 16% - Trefis
Viatris Stock Rockets 16% With 5-Day Winning Streak - Trefis
Viatris stock hits 52-week high at $16.63 By Investing.com - Investing.com Nigeria
Viatris Q1 2026 Earnings Call Transcript - MarketBeat
Assessing Viatris (VTRS) Valuation After Its Recent Share Price Rebound - Yahoo Finance
Viatris Inc. stock rises Thursday, outperforms market - MSN
Viatris (VTRS) Jumps As Targets Rise And Pipeline Delivers - timothysykes.com
Viatris Earnings: Stable Base Business and Pipeline Progression Mark a Solid Start to 2026 - Morningstar
Viatris (NASDAQ: VTRS) returns to profit as sales rise in Q1 2026 - Stock Titan
Viatris (VTRS) Q1 2026 Earnings Call Transcript - Fortune
Viatris Q1 EPS Beats Estimates, Revenues up 8% Driven by Greater China - sharewise.com
Viatris signals 2026 cash deployment of more than $2.5B while expecting Greater China mid- to high-single-digit growth - MSN
Viatris Releases Q1 2026 Financial Results - AlphaStreet
Viatris (VTRS) Q4 2025 Earnings Call Transcript - Fortune
After Kicking Off 2026 Solidly, Viatris Looks to New Launches and Cost Savings for Long-term Growth - Morningstar
Viatris’ Turnaround Story Is Paying Off in the Stock - Finimize
Viatris Q1 2026 slides: earnings beat drives shares higher - Investing.com
Viatris reports Q1 adjusted EPS 59c, consensus 50c - TipRanks
Earnings call transcript: Viatris Q1 2026 beats earnings expectations - Investing.com
Viatris beats quarterly estimates on China strength, branded drug sales - TradingView
Earnings call transcript: Viatris Q1 2026 beats earnings expectations By Investing.com - Investing.com UK
Viatris stock hits 52-week high at $16.63 - Investing.com
Here's What Key Metrics Tell Us About Viatris (VTRS) Q1 Earnings - Yahoo Finance
Viatris stock rises after Q1 2026 beat (VTRS:NASDAQ) - Seeking Alpha
Viatris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Viatris Delivers Strong Q1 2026 Results, Reaffirms Guidance - TipRanks
Viatris Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:VTRS) 2026-05-07 - Seeking Alpha
Viatris (VTRS) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
(VTRS) Viatris Expects 2026 Adjusted EPS Range $2.33$2.47, vs. FactSet Est of $2.44 - marketscreener.com
Viatris (NASDAQ:VTRS) Shares Rise as Q1 Earnings Top Estimates - ChartMill
Viatris Q1 Adjusted Earnings, Revenue Rise; Reaffirms 2026 Guidance - marketscreener.com
Earnings Flash (VTRS) Viatris Inc. Posts Q1 Adjusted EPS $0.59 per Share, vs. FactSet Est of $0.50 - marketscreener.com
Earnings Flash (VTRS) Viatris Inc. Reports Q1 Revenue $3.52B, vs. FactSet Est of $3.36B - marketscreener.com
Viatris shares slip 3% despite earnings beat on soft guidance By Investing.com - Investing.com Canada
Viatris Reports First-Quarter 2026 Financial Results - Viatris Newsroom
Viatris : VTRS Q1 2026 Non-GAAP ReconciliationsFINAL - marketscreener.com
Viatris : VTRS Q1 2026 Earnings PresentationFINAL - marketscreener.com
Viatris’s (NASDAQ:VTRS) Q1 CY2026: Beats On Revenue - Yahoo Finance
Earnings Flash (VTRS) Viatris Inc. Posts Q1 Adjusted EPS $0.59 per Share, Vs. FactSet Est of $0.50 - Moomoo
Viatris Inc Azioni (VTRS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.74%
1.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):